September 2026
The regulatory affairs outsourcing market size was valued at USD 8.39 billion in 2026 and is projected to hit around USD 15.98 billion by 2035 with a CAGR of 7.48%.
May 2026
The global regulatory affairs market size was valued at USD 17.29 billion in 2025 and is expected to hit around USD 38.68 billion by 2035, growing at a CAGR of 8.38%.
September 2026
The US regulatory affairs market size was USD 4.64 billion in 2026, with leading US regulatory affairs market players including WuXi AppTec, ProPharma, PharmaLex (Cencora).
September 2026
The global medical affairs outsourcing market size is valued at USD 2.23 billion in 2026 and is expected to hit around USD 4.12 billion by 2035, at a CAGR of 7.07%.
September 2026
The regulatory information management system market size is expected to hit around USD 6.81 billion by 2035 from USD 2.83 billion in 2026, with a notable CAGR of 10.28%.
September 2026
The global phentermine hydrochloride market size was evaluated at USD 649.27 million in 2026 and is predicted to hit around USD 1,115.57 million by 2034, growing at a CAGR of 7.00%.
September 2026
The AI in regulatory technology market size reached USD 22.72 billion in 2026, with leading AI in regulatory technology market companies including IBM Corporation, Microsoft Corporation, Oracle Corporation, Thomson Reuters.
May 2026
The global medical, legal, and regulatory (MLR) review software market size was evaluated at USD 17.09 billion in 2025 and is predicted to hit around USD 42.42 billion by 2035, growing at a CAGR of 9.52%.
March 2026
The U.S. medical affairs outsourcing market size was exhibited at USD 625.10 million in 2025 and is projected to touch USD 1,218.8 million by 2035, registering a CAGR of 6.91% from 2026 to 2035.
February 2026
The global regulatory compliance advisory services for utilities market focuses on helping power, water, and gas utilities meet evolving regulations, manage risk, and ensure operational compliance.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
September 2026
The global Cystatin C assay market size is exhibited at USD 339.98 million in 2026 and is projected to hit around USD 616.35 million by 2034, with a CAGR of 7.72%.
September 2026
The global non-invasive blood pressure monitors market size is expected to hit around USD 63.18 billion by 2035 from USD 34.61 billion in 2025, with a CAGR of 6.93%.
September 2026
The opioids market was valued at USD 23.77 billion in 2026, with leading companies including Mallinckrodt Pharmaceuticals LLC, Purdue Pharmaceuticals L.P., Teva Pharmaceuticals Inc.
September 2026
The global healthcare consumables market is estimated to hit around USD 231.66 billion by 2035, increasing from USD 175.29 billion in 2026, with a CAGR of 3.21%.
September 2026
The global microbiology testing market size reached USD 6.88 billion in 2026 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
September 2026
The global medical ceramics market size is estimated to hit around USD 40.20 billion by 2035 increasing from USD 23.53 billion in 2026, with a CAGR of 6.14%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The biosimilar monoclonal antibody market was valued at USD 19.73 billion in 2026, with leading companies including Roche, Mylan, Biogen.
September 2026
The global virtual ICU market size accounted for USD 91.54 billion in 2026 and is expected to reach over USD 127.78 billion by 2035, growing at a CAGR of 16.04%.
September 2026
The global homeopathic products market size was valued at USD 17.25 billion in 2026 and is expected to hit around USD 48.07 billion by 2035, at a CAGR of 12.01%.
September 2026
The pharmaceutical intermediates market is valued at USD 38.90 billion in 2026 and is expected to hit around USD 59.70 billion by 2035, growing at a CAGR of 4.89% from 2026 to 2035.
September 2026
The tendonitis treatment market size was calculated at USD 249.63 billion in 2026 and is projected to hit around USD 340.22 billion by 2035 with a CAGR of 3.50%.
September 2026
The global biosimilars market size is exhibited at USD 47.36 billion in 2026 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.
September 2026
The preclinical CRO market size was valued at USD 7.29 billion in 2026 and is expected to hit around USD 14.01 billion by 2035, growing at a CAGR of 7.56%.
September 2026
The global telehealth market size stood at USD 244.30 billion in 2026 and is poised to hit approximately USD 1367.36 billion by 2035, with a CAGR of 21.39%.
September 2026
The global women's health app market size is calculated at USD 5.15 billion in 2026 and is projected to hit around USD 22.18 billion by 2035 with a CAGR of 17.83%.
September 2026
The substance abuse treatment market size is expected to increase from USD 36.83 billion by 2034 from USD 17.23 billion in 2026 with a solid CAGR of 10.05%.
September 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 2.13 billion in 2026, with a CAGR of 7.12%.
September 2026
The continuous glucose monitoring device market size was valued at USD 6.16 billion in 2026 and is expected to hit USD 11.23 billion by 2035, registering a CAGR of 6.94%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com